Susan Windham-Bannister

Insider Reports History

Entity
Individual
Location
78 Blanchard Road, Burlington, Massachusetts
Signature
/s/ Susan Windham-Bannister
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Susan Windham-Bannister:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Aridis Pharmaceuticals, Inc. Director Stock options 261 K Jun 27, 2024 Direct
Humacyte, Inc. Director Stock Options (right to buy) 50 K Jun 13, 2024 Direct
Histogen Inc. Director Stock Option (right to buy) 6.84 K Jun 20, 2023 Direct

Insider Reports Filed by Susan Windham-Bannister

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ARDS Aridis Pharmaceuticals, Inc. Jun 27, 2024 1 $0 4 Jun 28, 2024 Director
HUMA Humacyte, Inc. Jun 13, 2024 1 $0 4 Jun 17, 2024 Director
ARDS Aridis Pharmaceuticals, Inc. Sep 18, 2023 1 $0 4 Sep 19, 2023 Director
HSTO Histogen Inc. Jun 20, 2023 1 $0 4 Jun 21, 2023 Director
HUMA Humacyte, Inc. Jun 15, 2023 1 $0 4 Jun 16, 2023 Director
ARDS Aridis Pharmaceuticals, Inc. May 4, 2023 3 $0 4 Jun 15, 2023 Director
ARDS Aridis Pharmaceuticals, Inc. Dec 5, 2022 1 $0 4 Dec 7, 2022 Director
HUMA Humacyte, Inc. Jun 9, 2022 1 $0 4 Jun 13, 2022 Director
HSTO Histogen Inc. Jun 1, 2022 1 $0 4 Jun 3, 2022 Director
HUMA Humacyte, Inc. Oct 13, 2021 1 $0 4 Oct 15, 2021 Director
ARDS Aridis Pharmaceuticals, Inc. Oct 4, 2021 1 $0 4 Oct 5, 2021 Director
HUMA Humacyte, Inc. Aug 26, 2021 0 $0 3 Aug 27, 2021 Director